Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR]).
Damman P, Varenhorst C, Koul S, Eriksson P, Erlinge D, Lagerqvist B, James SK. Damman P, et al. Among authors: varenhorst c. Am J Cardiol. 2014 Jan 1;113(1):64-9. doi: 10.1016/j.amjcard.2013.09.019. Epub 2013 Oct 3. Am J Cardiol. 2014. PMID: 24169009 Clinical Trial.
Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report.
Grimfjärd P, Erlinge D, Koul S, Lagerqvist B, Svennblad B, Varenhorst C, James S. Grimfjärd P, et al. Among authors: varenhorst c. Am Heart J. 2016 Jun;176:78-82. doi: 10.1016/j.ahj.2016.02.018. Epub 2016 Mar 12. Am Heart J. 2016. PMID: 27264223
Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
Sahlén A, Varenhorst C, Lagerqvist B, Renlund H, Wallentin L, James SK, Jernberg T. Sahlén A, et al. Among authors: varenhorst c. Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):5-12. doi: 10.1093/ehjcvp/pvv034. Epub 2015 Aug 28. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27533056
Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease.
Carrero JJ, Varenhorst C, Jensevik K, Szummer K, Lagerqvist B, Evans M, Spaak J, Held C, James S, Jernberg T. Carrero JJ, et al. Among authors: varenhorst c. Kidney Int. 2017 Jan;91(1):216-226. doi: 10.1016/j.kint.2016.09.014. Epub 2016 Nov 16. Kidney Int. 2017. PMID: 27865441 Free article.
67 results